Please assess the completion status of the following clinical trial:

Trial Title: DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients 18 years of age or older infected with HIV and weigh at least 40 kg.~* Plasma HIV RNA viral load of 1000 copies/mL or greater and CD4 count of 100 cells/mL or greater~* Be willing to use two forms of contraception throughout study~* No previous exposure to antiretroviral (ARV) drugs~Exclusion Criteria:~* Pregnancy or breastfeeding~* Physical or psychiatric disability~* Proven or suspected acute hepatitis within 30 days prior to study entry~* Active AIDS-defining opportunistic infection or disease~* History of acute or chronic pancreatitis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).